ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Five New Members Appointed To The National Cancer Advisory Board

July 8, 2011

Blochs to Sponsor “Fighting Cancer”

May 9, 1986

ACCC Considers Role Of Allied Personnel, Funds, Center Components

February 13, 1976

NIH To Replace RAC With New Committee

July 19, 1996

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012